Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 1;118(13):3417-25.
doi: 10.1002/cncr.26471. Epub 2012 Jan 9.

When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response

Affiliations

When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response

Angela R Bradbury et al. Cancer. .

Abstract

Background: BRCA1/2 testing is not recommended for children, as risk reduction measures and screening are not generally recommended before 25 years old (YO). Little is known about the prevalence and predictors of parent communication to offspring and how offspring respond to this communication.

Methods: Semi-structured interviews were conducted with parents who had BRCA1/2 testing and at least 1 child <25 YO. Logistic regressions were utilized to evaluate associations with communication. Framework analysis was utilized to analyze open-ended responses.

Results: A total of 253 parents completed interviews (61% response rate), reporting on 505 offspring. Twenty-nine percent of parents were BRCA1/2 mutation carriers. Three hundred thirty-four (66%) offspring learned of their parent's test result. Older offspring age (P ≤ .01), offspring gender (female, P = .05), parents' negative test result (P = .03), and parents' education (high school only, P = .02) were associated with communication to offspring. The most frequently reported initial offspring responses were neutral (41%) or relief (28%). Thirteen percent of offspring were reported to experience concern or distress (11%) in response to parental communication of their test results. Distress was more frequently perceived among offspring learning of their parent's BRCA1/2 positive or variant of uncertain significance result.

Conclusions: Many parents communicate their BRCA1/2 test results to young offspring. Parents' perceptions of offspring responses appear to vary by offspring age and parent test result. A better understanding of how young offspring respond to information about hereditary risk for adult cancer could provide opportunities to optimize adaptive psychosocial responses to risk information and performance of health behaviors, in adolescence and throughout an at-risk life span.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement There are no conflicts of interest to disclose.

Figures

Fig 1
Fig 1
a. Parent disclosure of BRCA1/2 test results by parent test result (n=505 offspring) *p-value=0.015 for hypothesis test of general difference in disclosure rates among genetic test result groups using Wald test from GEE-fit logistic regression. TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation b. Parental disclosure of BRCA1/2 test results by offspring event age* (n=505 offspring) *offspring age when their parent disclosed parent’s test results to offspring, or if parent did not disclose their test result to offspring, the age of child at study interview **p-value<0.001 for hypothesis test of general difference in disclosure rates among age groups using Wald test from GEE-fit logistic regression.
Fig 1
Fig 1
a. Parent disclosure of BRCA1/2 test results by parent test result (n=505 offspring) *p-value=0.015 for hypothesis test of general difference in disclosure rates among genetic test result groups using Wald test from GEE-fit logistic regression. TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation b. Parental disclosure of BRCA1/2 test results by offspring event age* (n=505 offspring) *offspring age when their parent disclosed parent’s test results to offspring, or if parent did not disclose their test result to offspring, the age of child at study interview **p-value<0.001 for hypothesis test of general difference in disclosure rates among age groups using Wald test from GEE-fit logistic regression.
Figure 2
Figure 2
A. Perceived offspring responses by parent test result TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation B. Perceived offspring responses by offspring age at disclosure C. Perceived offspring responses by offspring gender
Figure 2
Figure 2
A. Perceived offspring responses by parent test result TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation B. Perceived offspring responses by offspring age at disclosure C. Perceived offspring responses by offspring gender
Figure 2
Figure 2
A. Perceived offspring responses by parent test result TN = true negative test result, UN = uninformative negative test result (negative mutation without a known BRCA1/2 mutation in the family), VUS = variant of uncertain significance, POS = BRCA1/2 mutation B. Perceived offspring responses by offspring age at disclosure C. Perceived offspring responses by offspring gender

Similar articles

Cited by

References

    1. Khoury MJ, Gwinn M, Yoon PW, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–74. - PubMed
    1. Burke W, Psaty BM. Personalized medicine in the era of genomics. Jama. 2007;298:1682–4. - PubMed
    1. Olopade OI, Grushko TA, Nanda R, et al. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res. 2008;14:7988–99. - PMC - PubMed
    1. Calzone KA, Soballe PW. Genetic testing for cancer susceptibility. Surg Clin North Am. 2008;88:705–21. v. - PubMed
    1. Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 28:893–901. - PubMed

Publication types